• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Risk of Reinfection and Incidence of Chronic Symptoms After SARS-CoV-2 Infections

tetano

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2024 Oct 15;11(10):ofae608.
doi: 10.1093/ofid/ofae608. eCollection 2024 Oct. Risk of Reinfection and Incidence of Chronic Symptoms After SARS-CoV-2 Infections

Liam Golding[SUP] 1 2 [/SUP], Allison W Watts[SUP] 1 2 [/SUP], Mark Pitblado[SUP] 1 [/SUP], Felicity Clemens[SUP] 3 [/SUP], Marina Viñeta Paramo[SUP] 1 2 [/SUP], Jacob Shew[SUP] 1 2 [/SUP], Michael A Irvine[SUP] 3 [/SUP], Bahaa Abu-Raya[SUP] 1 2 4 [/SUP], David M Goldfarb[SUP] 1 5 [/SUP], Louise C Mâsse[SUP] 1 6 [/SUP], Pascal M Lavoie[SUP] 1 2 [/SUP]



Affiliations
Abstract

This study showed that a severe acute respiratory syndrome coronavirus 2 infection reduced the risk of reinfection among vaccinated individuals by 0.50 (95% CI, 0.39-0.64) over a 1-year period, after accounting for unreported infections using avidity-based serology. Reciprocally, chronic symptoms increased from a baseline of 21% (95% CI, 16%-28%) among infection-naïve individuals to 43% (95% CI, 30%-61%) in reinfected individuals.

Keywords: COVID-19; Omicron; SARS-CoV-2; post-COVID symptoms; serology.

​
 
You must log in or register to reply here.
Back
Top Bottom